Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2025-12-25 @ 10:50 PM
NCT ID: NCT01181167
Description: None
Frequency Threshold: 3
Time Frame: None
Study: NCT01181167
Study Brief: A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
DU-176b DU-176b oral tablets, 30 mg., taken once daily for 2 weeks edoxaban None None 9 303 197 303 View
Enoxaparin Sodium enoxaparin sodium 20mg(=2000IU)/0.2ml twice daily, subcutaneous injection for 2 weeks enoxaparin sodium None None 9 301 232 301 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
femur fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA/JV.12.0 View
otrhostatic hypotension SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA/JV.12.0 View
Dislocation of joint prosthesis SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA/JV.12.0 View
lacunar infarction SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA/JV.12.0 View
intestinal obstruction SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA/JV.12.0 View
postoperative wound infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA/JV.12.0 View
hip fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA/JV.12.0 View
abcess jaw SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA/JV.12.0 View
Transient ischaemic attack SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA/JV.12.0 View
Subarachnoid haemorrhage SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA/JV.12.0 View
gastroenteritis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA/JV.12.0 View
deep vein thrombosis SYSTEMATIC_ASSESSMENT Vascular disorders MedDRA/JV.12.0 View
pelvic fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA/JV.12.0 View
herpes zoster SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA/JV.12.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Aspartate aminotransferase increased SYSTEMATIC_ASSESSMENT Investigations MedDRA/JV.12.0 View
Gamma-glutamyltransferase increased SYSTEMATIC_ASSESSMENT Investigations MedDRA/JV.12.0 View
Blood urine present SYSTEMATIC_ASSESSMENT Investigations MedDRA/JV.12.0 View
Blood alkaline phosphatase increased SYSTEMATIC_ASSESSMENT Investigations MedDRA/JV.12.0 View
Haemorrhage subcutaneous SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders MedDRA/JV.12.0 View
Blood bilirubin increased SYSTEMATIC_ASSESSMENT Investigations MedDRA/JV.12.0 View
headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA/JV.12.0 View
Abdominal discomfort SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA/JV.12.0 View
Haematuria SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA/JV.12.0 View
Alanine aminotransferase increased SYSTEMATIC_ASSESSMENT Investigations MedDRA/JV.12.0 View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA/JV.12.0 View